Regional characteristics of biotechnology in the United States
Subtitle: perspectives of three industry insiders
By: interviews with Hugh A. D'Andrade, David P. Holveck, Edward E. Penhoet. Interviews conducted by Sally Smith Hughes in 1998 and 1999. Regional Oral History Office, The Bancroft Library, University of California, Berkeley,
Contributors: D'Andrade, Hugh A., 1938-; Holveck, David P., 1945-; Penhoet, Edward E., 1940-; Hughes, Sally Smith.; Bancroft Library. Regional Oral History Office.
Published: 2001
Subjects: University of California, Berkeley. Dept. of Biochemistry -- Faculty.; Schering-Plough Corporation.; Centocor, Inc.; Chiron Corporation.; Biotechnology industries -- United States.; Biotechnology -- United States.; Recombinant DNA -- Research.; Monoclonal antibodies -- Research.; Biotechnologists -- United States -- Interviews.
Genres: Interviews.
Description: Hugh A. D'Andrade (b. 1938): Executive with Schering-Plough Corp., 1981-present; Schering-Plough alliances with Biogen and DNAX Research Institute; commercializing recombinant DNA technology at Biogen and DNAX; biotechnology in New Jersey; comments on BIO (Biotechnology Industry Organization). David P. Holveck (b. 1945): CEO Centocor, 1983-present; work on monoclonal antibody diagnostics and therapeutics, forward integration; partnering with Eli Lilly, corporate, culture; biotechnology in Pennsylvania. Edward E. Penhoet (b. 1940): education, Stanford, Illinois and Washington; biochemistry professor, UC Berkeley, 1970-present; president and CEO, Chiron Corp., 1981-1998; discusses Chiron founders, financing, commercialization of recombinant DNA, staff recruitment, corporate growth, bioentrepreneurs.

includes research files on Hugh D'Andrade and David Holveck.